Announcements Trials
Browse Landscape

Phase

Phase 3 9Phase 2 9Phase EARLY_PHASE1 3Phase 4 3Phase 1/2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Ovarian Neoplasms 1Osteopetrosis, mild autosomal recessive form 1Osteopetrosis, Autosomal Recessive 7 1

Interventions

Letrozole 7Fluorodeoxyglucose F18 7Magnetic Resonance Spectroscopy 5Blood Specimen Collection 5pembrolizumab 4atezolizumab 4Trastuzumab 4Oncolytic Virotherapy 4Bevacizumab 4palbociclib 3Saline Solution 3Fish Oils 3Docosahexaenoic Acids 3Denosumab 3Carboplatin 3Biopsy 3pertuzumab 2olaparib 2Vitamin D 2Vinorelbine 2Taxes 2Sentinel Lymph Node Biopsy 2Radiotherapy 2Positron-Emission Tomography 2Positron Emission Tomography Computed Tomography 2Paclitaxel 2Omacor 2Neoadjuvant Therapy 2Metformin 2Lapatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Breast Neoplasms × Denosumab × Clear all
NCT03629717 2024-10-16

RANKL Inhibition and Breast Tissue Biomarkers

Washington University School of Medicine

Phase EARLY_PHASE1 Completed
10 enrolled
Breast

Breast Neoplasms

NCT03691311 2021-11-03

D-BIOMARK

Institut Català d'Oncologia

Phase EARLY_PHASE1 Unknown
60 enrolled
Breast

Osteopetrosis, mild autosomal recessive form, Osteopetrosis, Autosomal Recessive 7, Breast Neoplasms

NCT02900469 2020-08-21

Presurgical Trial of Denosumab in Breast Cancer

NYU Langone Health

Phase EARLY_PHASE1 Completed
44 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡